Upcoming Earnings: Q2 '26
Estimated EPS
$0.11
Estimated Rev
$20.2M
$OPRX Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.03 up 75.00% YoY • Reported revenue of $19.84M down -9.50% YoY • OptimizeRx updated its fiscal year 2026 guidance, now expecting revenue of $95M to $100M and adjusted EBITDA of $21M to $25M for the year.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q2 '26 | $0.11 | -- | -- | N/A |
Q1 '26 | $0.00 | $0.14 | 4100.42% | BEAT |
Q4 '25 | $0.22 | $0.51 | 127.32% | BEAT |
Q3 '25 | $0.04 | $0.20 | 442.01% | BEAT |
Q2 '25 | $0.02 | $0.24 | 1333.43% | BEAT |